6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow pardoprunox: new trials by email Literature Review of pardoprunox trials Research Report on pardoprunox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations. Pardoprunox - Advanced Stage Parkinson's Disease | Phase 3 | Completed | Solvay Pharmaceuticals | 140 | 2007-08-01 | 2010-09-13 |
| An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients Pardoprunox - Early Stage Parkinson's Disease | Phase 3 | Completed | Solvay Pharmaceuticals | 202 | 2007-08-01 | 2009-02-06 |
| SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations Levodopa (Pardoprunox), Placebo Comparator - Advanced Stage Parkinson's Disease | Phase 3 | Completed | Solvay Pharmaceuticals | 295 | 2007-03-01 | 2015-02-27 |
| An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients Pardoprunox - Early Stage Parkinson's Disease | Phase 3 | Completed | Solvay Pharmaceuticals | 224 | 2007-02-01 | 2009-01-26 |
| SLV308 for Treatment of Patients With Early Parkinson's Disease pardoprunox, Pardoprunox, Placebo - Early Stage Parkinson's Disease | Phase 3 | Completed | Solvay Pharmaceuticals | 468 | 2006-06-01 | 2008-08-29 |
| Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease SLV308 - Parkinson's Disease | Phase 3 | Completed | Solvay Pharmaceuticals | 2005-10-01 | 2009-01-30 |
Bulgaria (5) · United States (5) · Argentina (4) · Canada (4) · Chile (4) · Colombia (4) · Peru (4) · Russia (4) · Ukraine (4) · India (3) · Lithuania (3) · Serbia (3) · South Africa (3) · Belgium (2) · Brazil (2)
Erik Vanleeuwen (1)